share_log

SVB Leerink Maintains Outperform on Replimune Group, Lowers Price Target to $30

Benzinga Real-time News ·  Oct 3, 2022 06:22

SVB Leerink analyst Jonathan Chang maintains Replimune Group (NASDAQ:REPL) with a Outperform and lowers the price target from $37 to $30.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment